https://www.onclive.com/onclive-tv/dr-grothey-on-fda-approval-of-pembrolizumab-in-msihigh-crc
Dr. Grothey on FDA Approval of Pembrolizumab in MSI-High CRC

Axel Grothey, MD



Axel Grothey, MD, medical oncologist at Mayo Clinic, discusses the FDA approval of pembrolizumab (Keytruda) for the treatment of patients with microsatellite instability-high colorectal cancer (CRC).
Printer Printing...